AVNS Q2 2023 Earnings — Avanos Medical, Inc. Revenue & Financial Results | Market Cap Arena

AVNSAvanos Medical, Inc.

$621M

Q2 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$169M-0.9% YoY

Gross Profit

$98M57.7% margin

Operating Income

$12M7.0% margin

Net Income

-$68M-40.2% margin

EPS (Diluted)

$-1.46

QoQ Revenue Growth

+6.3%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$7M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$432M

Stockholders' Equity

$1.2B

Cash & Equivalents

$82M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$169M	$171M	-0.9%
Gross Profit	$98M	$102M	-3.7%
Operating Income	$12M	$12M	+0.0%
Net Income	-$68M	$13M	-644.8%

Revenue Segments

Digestive Health

$93M69%

Interventional pain

$42M31%